In the present study, we established the new prognostic model based on S100 family members and systematically analyzed its role in discriminating different subsets of HCC patients in many aspects, including prognosis, genetic mutations, phenotypic traits, predictive therapeutic efficacy and the abundance of infiltrating immune cell. The gene discussed is S100A1; the disease is hepatocellular carcinoma.